Remus Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
No Data Available
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 79.16 | 63.94 | 45.03 |
| Operating Expenses Annual | 53.18 | 42.94 | 34.48 |
| Operating Profit Annual | 28.89 | 23.81 | 12.12 |
| Interest Annual | 0.38 | 0.34 | 0.23 |
| Depreciation | 1.19 | 0.88 | 0.48 |
| Net Profit Annual | 19.90 | 16.62 | 8.50 |
| Tax Annual | 6.74 | 5.73 | 2.91 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 79.16 |
| Operating Expenses Annual | 53.18 |
| Operating Profit Annual | 28.89 |
| Interest Annual | 0.38 |
| Depreciation | 1.19 |
| Net Profit Annual | 19.90 |
| Tax Annual | 6.74 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.71 | 1.01 | 1.15 |
| Cash Flow from Operations | 15.59 | 6.31 | 5.31 |
| Cash Flow from Investing | -12.42 | -47.24 | -15.19 |
| Cash Flow from Financing | -1.42 | 41.63 | 11.77 |
| Cash Flow at the End | 3.46 | 1.71 | 3.04 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.71 |
| Cash Flow from Operations | 15.59 |
| Cash Flow from Investing | -12.42 |
| Cash Flow from Financing | -1.42 |
| Cash Flow at the End | 3.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 36.50 | 37.24 | 26.92 |
| PBIT Margin (%) | 34.13 | 35.49 | 25.85 |
| PBT Margin (%) | -55.70 | -68.89 | -86.54 |
| Net PROFIT Margin (%) | 25.14 | 25.99 | 18.88 |
| Return On Networth / Equity (%) | 10.06 | 19.25 | 66.10 |
| Return On Networth /Employed (%) | 13.33 | 24.46 | 68.21 |
| Return On Assets (%) | 9.80 | 17.94 | 49.83 |
| Total Debt / Equity (X) | 0.02 | 0.07 | 0.32 |
| Asset Turnover Ratio (%) | 0.39 | 0.69 | 2.64 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 36.50 |
| PBIT Margin (%) | 34.13 |
| PBT Margin (%) | -55.70 |
| Net PROFIT Margin (%) | 25.14 |
| Return On Networth / Equity (%) | 10.06 |
| Return On Networth /Employed (%) | 13.33 |
| Return On Assets (%) | 9.80 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 0.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 7.07 | 5.06 | 2.54 |
| Total Current Assets Annual | 53.91 | 48.88 | 11.34 |
| Non Current Assets Annual | 226.40 | 134.61 | 23.32 |
| Total Shareholders Funds Annual | 242.22 | 153.55 | 19.14 |
| Total Assets Annual | 280.31 | 183.49 | 34.66 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 7.07 |
| Total Current Assets Annual | 53.91 |
| Non Current Assets Annual | 226.40 |
| Total Shareholders Funds Annual | 242.22 |
| Total Assets Annual | 280.31 |
No Data Availabe
